Eledon Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Eledon Pharmaceuticals

11/11/2021 22:41

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 66 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 65 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Eledon Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 66 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eledon Pharmaceuticals Inc shares had fallen by 20.4% this
quarter and lost 68.1% so far this year.
* The company reported a quarterly loss of $9.82 million.
* Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $29.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 10:41 p.m.
 ​All figures in US dollars unless otherwise stated